Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Editorial Board

Priya Satalkar ([email protected])

Dr Priya Satalkar brings in her broad multidisciplinary training into medicine, public health and epidemiology, medical anthropology and bioethics. She completed her PhD at the Institute for Biomedical Ethics in February 2016 and continues to work there as a postdoctoral researcher. She is also employed part time with the Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital of Basel since March 2016. Though trained in mixed methods research, all her recent and ongoing projects deploy qualitative research methods. Her PhD was on the ethical challenges of translational biomedical research of cutting edge medical technology such as nanomedicine, with a particular focus on first in human clinical trials. Currently she is working on two research projects at the Institute for Biomedical Ethics, both funded through Swiss Academy of Medical Sciences (SAMW). One of them explores the experience and perspectives of researchers in life sciences and medicine in Switzerland regarding research integrity. The other project investigates the scope, organisation, practice and ethical challenges of medical tourism to Switzerland. Her project at University Hospital Basel involves the analysis of reasons for and implications of discontinuation of clinical trials due to slow or low participant recruitment. Interdisciplinary investigation of various aspects of translational biomedical research is a common theme in all her research projects. She has a keen interest in science communication for the general public. She has participated in a number of public debates organised within the University of Basel and at other universities in Switzerland.

Click here to support US